Search Results - "Zhang, Ningping"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: a multi-center observational study by Liu, Qing, Liu, Mengling, Zou, Zhiguo, Lin, Jinyi, Zhang, Ningping, Zhao, Lin, Zhou, Jiahua, Zhou, Haojie, Zhou, Xin, Jiao, Xiaodong, Yu, Yiyi, Liu, Tianshu

    Published in Journal of translational medicine (29-08-2024)
    “…Treatment strategy against immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs) frequently requires other immunosuppressive…”
    Get full text
    Journal Article
  3. 3

    CD86 + /CD206 + tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma by Sun, Dalong, Luo, Tiancheng, Dong, Pingping, Zhang, Ningping, Chen, Jing, Zhang, Shuncai, Liu, Longzi, Dong, Ling, Zhang, Si

    Published in PeerJ (San Francisco, CA) (22-01-2020)
    “…As the main cellular ingredients of tumor microenvironment, tumor-associated macrophages (TAMs) play a vital role in tumor development and progression. Recent…”
    Get full text
    Journal Article
  4. 4

    CAPS1 Suppresses Tumorigenesis in Cholangiocarcinoma by Weng, Shuqiang, Janssen, Harry L. A., Zhang, Ningping, Tang, Wenqing, Bai, Encheng, Yang, Biwei, Dong, Ling

    Published in Digestive diseases and sciences (01-04-2020)
    “…Background CAPS1 (calcium-dependent activator protein for secretion) is a multi-domain protein involved in regulating exocytosis of synaptic vesicles and…”
    Get full text
    Journal Article
  5. 5

    Clinical characteristics and prognosis of liver injury induced by immune checkpoint inhibitors in patients with malignancies: A real‐world retrospective study by Jiang, Ying, Lv, Minzhi, Jin, Zhiping, Wu, Yi, Li, Xiaoyu, Zhang, Ningping

    Published in British journal of clinical pharmacology (01-11-2024)
    “…Aims Programmed cell death receptor (ligand)‐1 inhibitors (PD‐(L)1), as the preferred immunotherapy, have been widely used in the Chinese mainland and…”
    Get full text
    Journal Article
  6. 6

    Risk Factors of Immune-Mediated Hepatotoxicity Induced by Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis by Jiang, Ying, Li, Ranyi, Li, Xiaoyu, Zhang, Ningping

    Published in Current oncology (Toronto) (13-11-2024)
    “…Immune checkpoint inhibitors (ICIs) significantly improve survival, while immune-mediated hepatotoxicity (IMH) has been reported. To evaluate the incidence and…”
    Get full text
    Journal Article
  7. 7

    M2‐polarized tumor‐associated macrophages promote epithelial‐mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma by Sun, Dalong, Luo, Tiancheng, Dong, Pingping, Zhang, Ningping, Chen, Jing, Zhang, Shuncai, Dong, Ling, Janssen, Harry L. A., Zhang, Si

    Published in Journal of cellular biochemistry (01-04-2020)
    “…Tumor‐associated macrophages (TAMs) have been considered as a major component of the tumor microenvironment. However, the crosstalk between M2‐polarized…”
    Get full text
    Journal Article
  8. 8

    Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma by Dong, Pingping, Wang, Xiaoxiao, Liu, Longzi, Tang, Wenqing, Ma, Lijie, Zeng, Wenjiao, Sun, Shaoyang, Zhang, Li, Zhang, Ningping, Shen, Xizhong, Janssen, Harry L.A., Dong, Ling, Zhang, Si, Chen, She

    Published in Journal of hepatology (01-12-2020)
    “…Abnormal activation of mTORC1 signaling occurs at high frequency in hepatocellular carcinoma (HCC). However, the underlying causes of this aberrant activation…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B by Reijnders, Jurriën G.P, Perquin, Moniek J, Zhang, Ningping, Hansen, Bettina E, Janssen, Harry L.A

    Published in Gastroenterology (New York, N.Y. 1943) (01-08-2010)
    “…Background & Aims Inconsistencies in results and guideline recommendations regarding the durability of nucleos(t)ide analogue-induced hepatitis B e antigen…”
    Get full text
    Journal Article
  11. 11

    Integrated in silico‐in vitro analysis of systematic kinase gatekeeper mutation effects on pan‐kinase inhibitors in targeted liver cancer therapy by Zhang, Danying, Tang, Wenqing, Weng, Shuqiang, Zhang, Ningping, Luo, Tiancheng, Shen, Xizhong, Dong, Ling

    “…Kinase‐targeted therapy has been established as a widely used strategy to treat liver cancer. However, a number of kinase gatekeeper mutations are clinically…”
    Get full text
    Journal Article
  12. 12

    Photoacoustic venous blood pressure sensing: a feasibility study by Wang, Biao, Zhu, Luyao, Wang, Yiyun, Ma, Lili, Zhang, Wen, Gao, Feng, Zhang, Ningping, Gao, Fei

    “…Portal hypertension (PH) is defined as high blood pressure in the splanchnic venous system, which is the driver of life-threatening complications. Currently…”
    Get full text
    Conference Proceeding